
Research · Cancer Education
Kidney Cancer: Conflicting Adjuvant Immunotherapy Data and a Real Option for Non-Clear Cell Disease
We have yet to have truly confirmatory data for a benefit for adjuvant immunotherapy in kidney cancer.
By Benjamin A. Teply, MD





























